Seeing Is Believing
Ikena Oncology's activity chart (see below) currently has 29 price targets and 23 ratings on display.
Analysts average stock forecasts to be materialized ratio is 36.43% with an average time for these price targets to be met of 212.14 days.
Most recent stock forecast was given by from WEDBUSH on 25-Jul-2025. First documented stock forecast 20-Apr-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 25-Jul-2025
$23
$5.84 (34.03%)
$8
1 years 2 months 28 days ago
(25-Jul-2025)
0/5 (0%)
$5.84 (34.03%)
Buy Since 24-May-2023
$4
1 years 11 months 12 days ago
(11-Nov-2024)
2/6 (33.33%)
$-15.68 (-79.67%)
132
Buy Since 13-May-2022
$156
$138.84 (809.09%)
$13
3 years 5 months 7 days ago
(16-May-2023)
4/5 (80%)
$82.08 (111.04%)
503
Buy Since 23-Dec-2021
$22
$4.84 (28.21%)
$22
3 years 7 months 6 days ago
(17-Mar-2023)
3/4 (75%)
$-27.32 (-55.39%)
265
Buy Since 20-Apr-2021
$27
$9.84 (57.34%)
5 years 2 months 10 days ago
(13-Aug-2021)
1/3 (33.33%)
$-102.36 (-79.13%)
453
What is IKNA (Ikena Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on IKNA (Ikena Oncology)?
Which analyst has the most public recommendations on IKNA (Ikena Oncology)?
Which analyst is the currently most bullish on IKNA (Ikena Oncology)?
Which analyst is the currently most reserved on IKNA (Ikena Oncology)?